NFE2L3 and cancer: These results suggested that the NRF3-CPEB3-NRF1 translational repression axis is involved in cancer development by shunting ubiquitin-dependent protein degradation through the NRF1–26S proteasome regulatory axis to ubiquitin-independent protein degradation through the POMP-20S proteasome axis (Figure 2).